Table 1.
Details of BAPN-only mouse TAD model
Mouse age and strain | BAPN administration (dose; route; duration) | Occurrence of first death | TAD rate at the BAPN treatment end point | Reference |
Three weeks old; C57BL/6 | 1 g/(kg∙d); in drinking water; four weeks | NG | 88.9% TAD; 55.6% TAR | Jia et al., 2015 |
NG | 77.8% TAD; 33.3% TAR | Jia et al., 2017 | ||
Week 2 | 70.0% TAR | Xu et al., 2018 | ||
NG | 87.5% TAD; 37.5% TAR | Ren et al., 2018 | ||
Week 2 | 59.3% TAD | Han et al., 2018 | ||
Week 3 | 81.8% TAD; 42.4% TAR | Wang et al., 2018 | ||
NG | 80.0% TAD; 46.7% TAR | Zhou et al., 2019 | ||
Week 2 | 90.0% TAD; 70.0% TAR | Gao et al., 2019 |
BAPN: β-aminopropionitrile; NG: not given; TAD: thoracic aortic dissection; TAR: thoracic aortic rupture